Please login to the form below

Not currently logged in
Email:
Password:

TYK2 inhibitor

This page shows the latest TYK2 inhibitor news and features for those working in and with pharma, biotech and healthcare.

UPDATED: BMS completes Celgene merger after FTC okay

UPDATED: BMS completes Celgene merger after FTC okay

overlap with BMS’ TYK2 inhibitor BMS-986165 could give the combined company an overly-dominant position in the market. ... Otezla slots nicely into Amgen’s existing psoriasis and anti-inflammatory portfolio, which includes TNF inhibitor Enbrel

Latest news

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
...
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...